mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.007 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.008 |